NOD2 maybe a biomarker for the survival of kidney cancer patients

por Xu, Deguo, Zhang, Shuisheng, Zhang, Shenfeng, Liu, Hongmei, Li, Paiyun, Yu, Lili, Shang, Heli, Hou, Yong, Tian, Yuan
Publicado 2017

The overall safety evaluation of programmed cell death/programmed cell death ligand 1 (PD-1/PD-L1) treatment for lung cancer patients: An updated systematic review and meta-analysi...

por Shang, Heli, Zhang, Zewen, Feng, Alei, Yang, Xiaowei, Zhang, Shuisheng, Zhao, Yi, Zhu, Qingshan, Mao, Yantao, Liu, Kun, Tian, Yuan
Publicado 2019

Significance of CD8(+) T cell infiltration-related biomarkers and the corresponding prediction model for the prognosis of kidney renal clear cell carcinoma

por Tian, Yuan, Wei, Yumei, Liu, Hongmei, Shang, Heli, Xu, Yuedong, Wu, Tong, Liu, Wei, Huang, Alan, Dang, Qi, Sun, Yuping
Publicado 2021

Risk associated with central catheters for malignant tumor patients: a systematic review and meta-analysis

por Lv, Yajuan, Hou, Yong, Pan, Bo, Ma, Yuwan, Li, Paiyun, Yu, Lili, Xu, Deguo, Song, Juanjuan, Shang, Heli, Wang, Hongyan, Tian, Yuan
Publicado 2018

The Association Between the Incidence Risk of Peripheral Neuropathy and PD-1/PD-L1 Inhibitors in the Treatment for Solid Tumor Patients: A Systematic Review and Meta-Analysis

por Si, Zhihua, Zhang, Shuisheng, Yang, Xiaowei, Ding, Nan, Xiang, Meiyi, Zhu, Qingshan, Mao, Yantao, Lv, Yajuan, Yu, Lili, Shang, Heli, Xie, Jian, Tian, Yuan
Publicado 2019

Risk of Rash in PD-1 or PD-L1-Related Cancer Clinical Trials: A Systematic Review and Meta-Analysis

por Tian, Yuan, Zhang, Chi, Dang, Qi, Wang, Kaiyong, Liu, Qian, Liu, Hongmei, Shang, Heli, Zhao, Junyan, Xu, Yuedong, Wu, Tong, Liu, Wei, Yang, Xiaowei, Safi, Mohammed
Publicado 2022